Intensive Insulin Therapy in High-Risk Cardiac Surgery Patients: Evidence from the Leuven Randomized Study

Seminars in Thoracic and Cardiovascular Surgery

Volumn 18, Issue 4, 2006, Pages 309-316

  Vanhorebeek, Ilse ^a   Ingels, Catherine ^a   Van den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

cardiac surgery; critical illness; hyperglycemia; insulin; outcome

Indexed keywords

ANTIBIOTIC AGENT; GLUCOSE; INSULIN;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTEREMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DRUG COST; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HEART PROTECTION; HEMOFILTRATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE; LENGTH OF STAY; OPEN HEART SURGERY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; SURGICAL RISK; SURVIVAL TIME;

BLOOD GLUCOSE; CARDIAC SURGICAL PROCEDURES; CRITICAL ILLNESS; HEART DISEASES; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 33947512314     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2006.05.001     Document Type: Article

References (68)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
4. Mukamal K.J., Nesto R.W., Cohen M.C., et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 24 (2001) 1422-1427
5. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
6. Malmberg K., DIGAMI (Diabetes Mellitus, and Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 314 (1997) 1512-1515
7. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
8. Furnary A.P., Wu Y., and Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10 suppl 2 (2004) 21-33
9. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose lowers the risk of wound infection in diabetics after open heart surgery. Ann Thorac Surg 63 (1997) 356-361
10. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 (1999) 352-360
11. Thorell A., Nygren J., and Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 21 (1999) 69-78
12. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycaemia. Crit Care Clin 17 (2001) 107-124
13. Vanhorebeek I., Langouche L., and Van den Berghe G. Glycemic and non-glycemic effects of insulin: how do they contribute to a better outcome in critical illness?. Curr Opin Crit Care 11 (2005) 304-311
14. Mizock B.A. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 98 (1995) 75-84
15. Boord J.B., Graber A.L., Christman J.W., et al. Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med 164 (2001) 1763-1767
16. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78 (2003) 1471-1478
17. Faustino E.V., and Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 146 (2005) 30-34
18. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
19. Muhlestein J.B., Anderson J.L., Horne B.D., et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 146 (2003) 351-358
20. Suematsu Y., Sato H., Ohtsuka T., et al. Predictive risk factors for delayed extubation in patients undergoing coronary artery bypass grafting. Heart Vessels 15 (2000) 214-220
21. Yendamuri S., Fulda G.J., and Tinkoff G.H. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 55 (2003) 33-38
22. Laird A.M., Miller P.R., Kilgo P.D., et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 56 (2004) 1058-1062
23. Bochicchio G.V., Sung J., Joshi M., et al. Persistent hyperglycemia is predictive of outcome of critically ill trauma patients. J Trauma 58 (2005) 921-924
24. Sung J., Bochicchio G.V., Joshi M., et al. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 59 (2005) 80-83
25. Rovlias A., and Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46 (2000) 335-342
26. Jeremitsky E., Omert L.A., Dunham M., et al. The impact of hyperglycemia on patients with severe brain injury. J Trauma 58 (2005) 47-50
27. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32 (2001) 2426-2432
28. Gore D.C., Chinkes D., Heggers J., et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 51 (2001) 540-544
29. Bolton C.F. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24 (1996) 1408-1416
30. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
31. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 (2005) 1348-1353
32. Van den Berghe G., Wouters P.J., Kesteloot K., et al. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 34 (2006) 612-616
33. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in medical intensive care patients. New Engl J Med 354 (2006) 449-461
34. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
35. Grey N.J., and Perdrizet G.A. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 10 suppl 2 (2004) 46-52
36. Chaney M.A., Nikolov M.P., Blakeman B.P., et al. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg 89 (1999) 1091-1095
37. Carvalho G., Moore A., Qizilbash B., et al. Maintenance of normoglycemia during cardiac surgery. Anesth Analg 99 (2004) 319-324
38. Ingels C., Debaveye Y., Milants I., et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care and quality of life. Eur Heart J (2006) (in press)
39. Reis Miranda D., de Rijck A., and Schaufeli W. Simplified therapeutic intervention scoring system: the TISS-28 items-results from a multicenter study. Crit Care Med 24 (1996) 64-73
40. Yates J.W., Chalmer B., and McKegney F.P. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45 (1980) 2220-2224
41. Hunt S., McEwen J., and McKenna S. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 35 (1985) 185-188
42. Erdman R., and Passchier J. The Dutch version of the Nottingham Health Profile: investigation and psychometric aspects. Psychol Rep 72 (1993) 1027-1035
43. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
44. Finney S.J., Zekveld C., Elia A., et al. Glucose control and mortality in critically ill patients. JAMA 290 (2003) 2041-2047
45. Klip A., Tsakiridis T., Marette A., et al. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 8 (1994) 43-53
46. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J Clin Invest 114 (2004) 1187-1195
47. Vanhorebeek I., De Vos R., Mesotten D., et al. Strict blood glucose control with insulin in critically ill patients protects hepatocytic mitochondrial ultrastructure and function. Lancet 365 (2005) 53-59
48. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
49. Brealey D., Karyampudi S., Jacques T.S., et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 286 (2004) R491-R497
50. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 (2005) 2277-2286
51. Turina M., Fry D.E., and Polk Jr. H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 33 (2005) 1624-1633
52. Weekers F., Van Herck E., Coopmans W., et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a bi-phasic neuroendocrine stress response. Endocrinology 143 (2002) 764-774
53. Weekers F., Giuletti A.-P., Michalaki M., et al. Endocrine and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 (2003) 5329-5338
54. Mesotten D., Swinnen J.V., Vanderhoydonc F., et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89 (2004) 219-226
55. Vanhorebeek I., and Van den Berghe G. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Curr Opin Pharmacol 4 (2004) 621-628
56. Vanhorebeek I., Langouche L., and Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2 (2006) 20-31
57. Mesotten D., Wouters P.J., Peeters R.P., et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab 89 (2004) 3105-3113
58. Hansen T.K., Thiel S., Wouters P.J., et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients, as indicated by circulating mannose-binding lectin and C-reactive protein levels. J Clin Endocrinol Metab 88 (2003) 1082-1088
59. Jeschke M.G., Klein D., and Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 239 (2004) 553-560
60. Jeschke M.G., Klein D., Bolder U., et al. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145 (2004) 4084-4093
61. Klein D., Schubert T., Horch R.E., et al. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 240 (2004) 340-349
62. Das U.N. Insulin: an endogenous cardioprotector. Curr Opin Crit Care 9 (2003) 375-383
63. Jonassen A., Aasum E., Riemersma R., et al. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 14 (2000) 615-623
64. Gao F., Gao E., Yue T., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the role of PI3-kinase, Akt and eNOS phosphorylation. Circulation 105 (2002) 1497-1502
65. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. The CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-446
66. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI-2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
67. Ellger B., Debaveye Y., Vanhorebeek I., et al. Survival benefits of intensive insulin therapy in critical illness. Impact of normoglycemia versus glycemia-independent actions of insulin. Diabetes 55 (2006) 1096-1105
68. Mesotten D., Delhanty P.J., Vanderhoydonc F., et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87 (2002) 5516-5523